[1]赵静*,刘阳,熊媛珺,等.酪氨酸激酶受体RON与Ecadherin在子宫 内膜异位症上的表达及意义[J].中国计划生育和妇产科,2020,(5):85-88,92.
　ZHAO Jing*,LIU Yang,XIONG Yuanjun,et al.Expression and significance of tyrosine kinase receptor RON and Ecadherin in endometriosis[J].Chinese Journal of Family Planning & Gynecotokology,2020,(5):85-88,92.
点击复制

酪氨酸激酶受体RON与Ecadherin在子宫 内膜异位症上的表达及意义
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年5期
页码:
85-88,92
栏目:
论著与临床
出版日期:
2020-05-25

文章信息/Info

Title:
Expression and significance of tyrosine kinase receptor RON and Ecadherin in endometriosis
作者:
赵静1*; 刘阳2; 熊媛珺2;  李世彤2; 郭端英2
1.518109广东深圳，深圳市龙华区人民医院妇科；2.518172广东深圳，深圳市龙岗区人民医院妇产科
Author(s):
ZHAO Jing1*; LIU Yang2; XIONG Yuanjun2; LI Shitong2; GUO Duanying2
1.Department of Gynecology,Longhua District People's Hospital,Shenzhen Guangdong 518109, P.R.China;2. Department of Obstetrics and Gynecology, Longgang District People's Hospital, Shenzhen Guangdong 518172,P.R.China
关键词:
酪氨酸激酶受体; 上皮型钙粘蛋白; 子宫内膜异位症; 逆转录聚合酶链反应; 免疫组织化学
Keywords:
tyrosine kinase receptor RON; Ecadherin; endometriosis; reverse transcriptian polymerase chain reaction;  immunohistochemistry
分类号:
R 71171
摘要:
目的探讨酪氨酸激酶受体RON及上皮型钙粘蛋白（Ecadherin）在子宫内膜异位症（endometriosis，EMs）上的表达及意义。方法选择2017年7～12月深圳市龙岗区人民医院收治的42例EMs患者，术中分别留取新鲜异位内膜组织和在位内膜组织，随机选取子宫切除或诊断性刮宫治疗的非EMs患者42例，术中留取其正常子宫内膜组织。采用逆转录聚合酶链反应（RTPCR）检测子宫内膜组织中RON mRNA的表达，采用免疫组织化学方法检测对应42例石蜡组织中RON蛋白和Ecadherin的表达，并分析RON蛋白和Ecadherin的相关性。结果EMs异位内膜组织RON mRNA及RON蛋白阳性表达率显著高于在位内膜组织及正常子宫内膜组织（P＜0001），在位内膜组织及正常内膜组织中Ecadherin阳性表达率显著高于异位内膜组织(P＜0001),且异位内膜组织中RON mRNA及RON蛋白的表达与临床分期有关(P＜0001)。在同一标本中RON蛋白和Ecadherin表达呈负相关关系(r=-0497，P＜005)。结论RON的过度表达与EMs的发生发展密切相关，联合检测RON和Ecadherin的异常对判断EMs的发生发展有一定的参考价值，RON可能成为诊断治疗EMs的新靶点。
Abstract:
ObjectiveTo investigate the expression and significance of tyrosine kinase receptor RON and Ecadherin in endometriosis(EMs). MethodsTotally 42 patients with EMs were selected from July 2017 to December 2017 in Longgang District People's Hospital of Shenzhen as the study subjects, their ectopic endometrium and normal endometrium were obtained during the operation. Reverse transcriptian polymerase chain reaction(RTPCR) was used to detect the expression of RON mRNA.RON protein and Ecadherin expression were examined in corresponding 42 specimens paraffinembedded tissues by immunohistochemistry.The correlation between RON protein and Ecadherin expression in EMs eutopic endometrium was analyzed. ResultsThe positive rate of RON mRNA and RON protein in EMs eutopic endometrium were higher than those in the EMs ectopic endometrium and normal endometrium (P＜0001). The positive rate of Ecadherin in the EMs ectopic endometrium and normal endometrium were higher than those in the EMs eutopic endometrium (P＜0001).The RONmRNA and RON protein positive rate in EMs eutopic endometrium was significantly correlated(P＜0001). The expression of RON protein and Ecadherin had negative correlation in the same sample(r=-0497，P<005). ConclusionExcessive expression of RON is closely related to the progression of EMs. Combined detection of RON and Ecadherin may be helpful to evaluate the development of EMs, RON may be a new diagnostic/therapeutic targert of EMs.

参考文献/References:

［1］彭靖，张萌，李桂玲．子宫内膜异位症相关不孕的治疗进展 ［J］．国际生殖健康计划生育杂志，2017，36（1）：8286． ［2］Swiersz L M. Role of endometriosis in cancer and tumor development ［J］. Annals of the New York Academy of Sciences, 2002, 955(1): 281292. ［3］余晓雯，赵文权，吴连俊，等．受体酪氨酸激酶RON在上皮源性肿瘤靶向治疗中的研究进展 ［J］．中国肿瘤，2016，25（9）：711714． ［4］Chen Feifei, Liu Xin, Cheng Qian, et al. RUNX3 regulates renal cell carcinoma metastasis via targeting miR6780a5p/Ecadherin/EMT signaling axis ［J］. Oncotarget, 2017, 8(60): 101042101056. ［5］Listed N. Revised American society for reproductive medicine classification of endometriosis:1996 ［J］. Fertility&Sterility, 1997, 67(5): 817821. ［6］申洪，孙东瑾．免疫组化细胞核阳性指数测试中的放大倍数效应 ［C］//第十五届中国体视学与图像分析学术会议．中国广西南宁，2017：1． ［7］杨东霞，姚慧，李红梅，等．子宫内膜异位症发病机制的研究进展 ［J］．实用妇科内分泌电子杂志，2019，6（22）：28． ［8］Rosin C, Muscatelli M M. Anovel putative receptor protein tyrosine kinase of the Met family ［J］. Oncogene, 1993, 8(5):11951202. ［9］Chang K, Karnad A, Zhao S, et al. Roles of cMet and RON kinases in tumor progression and their potential as therapeutic targets ［J］. Oncotarget, 2015, 6(6): 35073518. ［10］Dey A, Allen J N, Fraser J W, et al. Neuroprotective Role of the Ron Receptor Tyrosine Kinase Underlying Central Nervous System Inflammation in Health and Disease ［J］. Frontiers in Immunology, 2018, 9:513526. ［11］庄晓苹，董晓峰，林琼琼．RON,HGF在子宫内膜癌中的表达及临床意义 ［J］．现代实用医学，2017，29（7）：911912，980. ［12］Liang Kh, Lai Jk, Kuan I I, et al. Abstract 327:EpCAM/EpEX regulate tumor progression through EGFR signaling in colon cancer cells ［J］. Cancer Research, 2017, 77(13 Supplement): 327327. ［13］Danilkovitch M A, Angeloni D, Skeel A, et al. Integrinmediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and cSrc ［J］. Journal of Biological Chemistry, 2000, 275(20): 1478314786. ［14］徐华丽, 杨孝明, 杜娜,等. UBE3C在雌激素促进子宫内膜癌细胞迁移及侵袭中的作用机制研究 ［J］. 现代妇产科进展, 2018, 27(5):1721，25. ［15］Gaetje R, Kotzian S, Herrmann G, et al. Nonmalignant epithelial cells,potentially invasive in human endometriosis,lack the tumor suppressor molecule E.Cadherin ［J］. American Journal of Pathology, 1997, 150(2): 461467. ［16］Thiery J P. Epithelialmesenchymal transitions in tumor progression ［J］. Nature Reviews Cancer, 2002, 2(6):442454. ［17］Yu R, Han L, Ni X, et al. Kruppellike factor 4 inhibits nonsmall cell lung cancer cell growth and aggressiveness by stimulating transforming growth factorβ1meidated ERK/JNK/NFκB signaling pathways ［J］. Tumour Biology the Journal of the International Society for Oncodevelopmental Biology & Medicine, 2017, 39(6):1010428317705574. ［18］Chen L, Li Z, Yan Z, et al. The role of the Wnt/βcatenin signaling pathway in the proliferation of Gold nanoparticletreated human periodontal ligament stem cells ［J］. Stem Cell Research & Therapy, 2018, 9(1): 214. ［19］马亮，陈俊丰，马琪．受体型酪氨酸激酶RON异构体:潜在的肿瘤治疗靶标 ［J］．中国生物化学与分子生物学报，2017，33（10）：985992． ［20］JiaYt, Yang Dh, Zhao Z, et al. Effects of PHA665752 and cetuximab combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with KRAS or BRAF mutations ［J］. Current Cancer Drug Targets, 2018, 18(3): 278286. ［21］孙珊，胡红玲，段晓宇，等．MEK1/2抑制剂PD98059对oxLDL诱导HUVEC损伤的保护机制及对LOX1表达影响 ［J］．重庆医学，2018，47（13）：2932．

备注/Memo

备注/Memo:
深圳市龙岗区经济与科技发展专项资金医疗卫生科技计划项目(扶持类)(项目编号:20170403150340108)
更新日期/Last Update: 2020-05-25